Addressing the need for greater access in vision care
Education, advancing technology are key to meeting patient needs
Top 10 questions about cross-linking
Keratoconus treatment has changed much over the past several years. Avedro’s U.S. Food and Drug Administration (FDA) approval of corneal cross-linking has given more patients hope for better vision.
2 Clarke Drive Cranbury, NJ 08512